The acromegaly lipodystrophy

por Freda, Pamela U.
Publicado 2022

Long-term Outcome of Body Composition, Ectopic Lipid, and Insulin Resistance Changes With Surgical Treatment of Acromegaly

por Kuker, Adriana P, Shen, Wei, Jin, Zhezhen, Chen, Jun, Bruce, Jeffrey N, Freda, Pamela U
Publicado 2023

Body Composition Changes with Long-term Pegvisomant Therapy of Acromegaly

por Kuker, Adriana P, Shen, Wei, Jin, Zhezhen, Singh, Simran, Chen, Jun, Bruce, Jeffrey N, Freda, Pamela U
Publicado 2021

SAT-438 Visceral and Marrow Adiposity in Patients with Acromegaly; Relationships to Disease Activity, Markers of Bone Turnover, Bone Mineral Density, and Peripheral Bone Microarchi...

por Kuker, Adriana, Mojahed, Hamed, Shen, Wei, Cohen, Adi, Arias-Mendoza, Fernando, Jin, Zhezhen, Cremers, Serge, Shane, Elizabeth, Freda, Pamela
Publicado 2019

Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline

por Freda, Pamela U., Beckers, Albert M., Katznelson, Laurence, Molitch, Mark E., Montori, Victor M., Post, Kalmon D., Vance, Mary Lee
Publicado 2011

MON-307 Prospective, Longitudinal Study of Glucose-Suppressed GH Levels in 87 Acromegaly Patients with IGF-1 Normalization After Surgical Therapy: Prognostic Value of Nadir GH Leve...

por Freda, Pamela, Bruce, Jeffrey N, Reyes-Vidal, Carlos, De Leon, Yessica, Jin, Zhezhen, Khandji, Alexander G, Cremers, Serge, Post, Kalmon D
Publicado 2020

Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multic...

por Sheppard, Michael, Bronstein, Marcello D., Freda, Pamela, Serri, Omar, De Marinis, Laura, Naves, Luciana, Rozhinskaya, Liudmila, Hermosillo Reséndiz, Karina, Ruffin, Matthieu, Chen, YinMiao, Colao, Annamaria
Publicado 2014

Erratum to: Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-b...

por Sheppard, Michael, Bronstein, Marcello D., Freda, Pamela, Serri, Omar, De Marinis, Laura, Naves, Luciana, Rozhinskaya, Liudmila, Hermosillo Reséndiz, Karina, Ruffin, Matthieu, Chen, YinMiao, Colao, Annamaria
Publicado 2015

Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study

por Freda, Pamela U, Bruce, Jeffrey N, Khandji, Alexander G, Jin, Zhezhen, Hickman, Richard A, Frey, Emily, Reyes-Vidal, Carlos, Otten, Marc, Wardlaw, Sharon L, Post, Kalmon D
Publicado 2020

Persistent Deficits in Bone Quality in Treated Acromegaly: Evidence From Assessments of Microstructure

por Kuker, Adriana P, Agarwal, Sanchita, Shane, Elizabeth, Cohen, Adi, Nickolas, Thomas L, Stein, Emily M, Reid, Tirissa J, Hans, Didier, Cremers, Serge, Bruce, Jeffrey N, Freda, Pamela U
Publicado 2023

MON-309 Prevalence of Silent Corticotroph Adenomas in a Large Cohort of Nonfunctioning Pituitary Adenomas: Plasma Proopiomelanocortin(POMC) Levels and Response to Pasireotide LAR

por Reyes-Vidal, Carlos, Page-Wilson, Gabrielle, Bruce, Jeffrey N, Post, Kalmon D, Hickman, Richard, Panigrahi, Sunil Kumar, Jin, Zhezhen, Khandji, Alexander, White, Anne, Wardlaw, Sharon L, Freda, Pamela
Publicado 2020

Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study

por Bronstein, Marcello D., Fleseriu, Maria, Neggers, Sebastian, Colao, Annamaria, Sheppard, Michael, Gu, Feng, Shen, Chiung-Chyi, Gadelha, Mônica, Farrall, Andrew J., Hermosillo Reséndiz, Karina, Ruffin, Matthieu, Chen, YinMiao, Freda, Pamela
Publicado 2016

A Pituitary Society update to acromegaly management guidelines

por Fleseriu, Maria, Biller, Beverly M. K., Freda, Pamela U., Gadelha, Monica R., Giustina, Andrea, Katznelson, Laurence, Molitch, Mark E., Samson, Susan L., Strasburger, Christian J., van der Lely, A. J., Melmed, Shlomo
Publicado 2020

THU070 Randomized, Placebo-controlled Phase 3 Trial Protocol Assessing The Efficacy And Safety Of Octreotide Subcutaneous Depot (CAM2029) In Patients With Acromegaly

por Ferone, Diego, Freda, Pamela, Katznelson, Laurence, Gatto, Federico, Gilis-Januszewska, Aleksandra, Gordon, Murray B, Kadioglu, Pinar, Maffei, Pietro, Seufert, Jochen R, Silverstein, Julie, Spencer-Segal, Joanna L, Harrie, Maria, Svedberg, Agneta, Tiberg, Fredrik
Publicado 2023

Safety Results From MPOWERED, a Phase 3 Trial of Oral Octreotide Capsules in Adults With Acromegaly

por Freda, Pamela, Fleseriu, Maria, Dreval, Akexander V, Pokramovich, Yulia, Bondar, Irina, Isaeva, Elena, Huang, Wenyu, Molitch, Mark E, Macut, Djuro P, Leonova, Nina, Raverot, Gerald, Gilgun-Sherki, Yossi, Ludlam, William H, Patou, Gary, Haviv, Asi, Gordon, Murray B, Biermasz, Nienke, Melmed, Shlomo, Strasburger, Christian J
Publicado 2021